shareholders can easily avoid dilution by buying a few shares....

shareholders can easily avoid dilution by buying a few shares.

The real number to look at is the total value of shares sold since the results announcement. Only around $2M worth has been traded, so, as of announcement date, around 2%, yet it has reduced market value by $25M, or around 20%.

to put that into perspective, PGC is about to pay out $4 mill in dividends for the half year. It also made $15 mil in net profit tax which on todays SP is 13.5% return after tax.
struggling to see the downside on buying more at these prices. Highly profitable defensive stock at 20 year lows. Management forecasting increased earnings for the next 2 years. And we have acquired 3 complimentary businesses including quantum.

it would not surprise me if the seller bought $2M worth of stock over the next six months to reset their position at a lower price. Risky strategy though, as if someone else with deep pockets realises the value here they could soak up the shares pretty quickly.

Anyone else have a medical stock in their portfolio with a greater return on investment I'd like to hear about it. Please post your tips. Happy to take your next best if you can't beat PGC